Pulsed electric field treatment has increased over the last few decades with successful translation from in vitro studies into different medical treatments like electrochemotherapy, irreversible electroporation for tumor and cardiac tissue ablation and gene electrotransfer for gene therapy and DNA vaccination. Pulsed electric field treatments are efficient but localized often requiring repeated applications to obtain results due to partial response and recurrence of disease. While these treatment times are several orders of magnitude lower than conventional biochemical treatment, it has been recently suggested that cells may become resistant to electroporation in repetitive treatments. In our study, we evaluate this possibility of developing adaptive resistance in cells exposed to pulsed electric field treatment over successive lifetimes. Mammalian cells were exposed to electroporation pulses for 30 generations. Every 5 th generation was analyzed by determining permeabilization and survival curve. No statistical difference between cells in control and cells exposed to pulsed electric field treatment was observed. We offer evidence that electroporation does not affect cells in a way that they would become less susceptible to pulsed electric field treatment. Our findings indicate pulsed electric field treatment can be used in repeated treatments with each treatment having equal efficiency to the initial treatment. Electroporation or pulsed electric field (PEF) treatment can cause increase in membrane permeability and allows molecules, for which the membrane is mostly impermeable, to cross. Two distinct outcomes of electroporation can be observed and used: reversible and irreversible electroporation. In reversible electroporation cells manage to repair the damage caused by electric pulses, i.e. cells survive. This has been widely used in different scientific fields for inserting molecules of interest into the cell. One of the more widely used applications is gene electro-transfer, which allows genetic manipulation. From a simple increased transfection this was developed into gene therapy 1,2 and DNA vaccination 3,4. While with gene therapy new genes and products are expressed within the host cell, DNA vaccination induces immune response of host organism. Combination of DNA vaccine injection and electroporation is most potent DNA delivery for subsequent immune response 5. Increased cell membrane permeability is also being exploited in electrochemotherapy (ECT). ECT is a combination of electric pulses and chemotherapeutic drug. Due to increased cell membrane permeability chemotherapeutic drug enter the cell which potentiates the cytotoxicity of the drug 6,7. ECT has been proved as a safe and efficient procedure for skin malignancies and now studies have been initiated to treat deep-seated tumors 8,9. The other possible outcome of electroporation is irreversible electroporation (IRE), where the damage to the cells is too extensive and leads to cell death. The use of irreversible electroporation as tissue ablation techn...